EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeted protein degrader development for cancer: advances, challenges, and opportunities

Yuan Fang, Shuhang Wang, Songzhe Han, Yizhou Zhao, Cunjing Yu, Huaqing Liu, Ning Li

Trends in Pharmacological Sciences · 2023-05 · 44 (5) · 303-317

DOI: 10.1016/j.tips.2023.03.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023-05. Verfasst von Yuan Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and …. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Health Commission, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansProteolysisDrug Delivery SystemsProteolysis Targeting Chimera

Stichwörter der Autor:innen

IMiDPROTACSERDcancerprotein degradation

Substanzen

Proteolysis Targeting Chimera

Autor:innen und Institutionen

  • Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Department of Chemistry, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
  • Translational Discovery, Research, and Medicine, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
  • Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic addres…

Förderung

  • Beijing Municipal Health Commission
  • Chinese Academy of Medical Sciences

Zitieren

APA

Fang, Y., Wang, S., Han, S., Zhao, Y., Yu, C., Liu, H., & Li, N. (2023). Targeted protein degrader development for cancer: advances, challenges, and opportunities. Trends in Pharmacological Sciences, 44(5), 303-317. https://doi.org/10.1016/j.tips.2023.03.003

Vancouver

Fang Y, Wang S, Han S, Zhao Y, Yu C, Liu H, et al. Targeted protein degrader development for cancer: advances, challenges, and opportunities. Trends in Pharmacological Sciences. 2023;44(5):303-317. doi:10.1016/j.tips.2023.03.003

BibTeX
@article{Fang2023,
  author = {Fang, Yuan and Wang, Shuhang and Han, Songzhe and Zhao, Yizhou and Yu, Cunjing and Liu, Huaqing and Li, Ning},
  title = {Targeted protein degrader development for cancer: advances, challenges, and opportunities},
  journal = {Trends in Pharmacological Sciences},
  year = {2023},
  volume = {44},
  number = {5},
  pages = {303--317},
  doi = {10.1016/j.tips.2023.03.003}
}
Kostenlos starten →